SCHEMBL20767178

SCHEMBL20767178

CN1CCC(CC(=O)N(Cc2ccc(F)cc2F)Cc2ccc(F)cc2F)CC1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 19/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20781011 0.89 HTR2A (0.50) HTR2A
SCHEMBL20767250 0.88 HTR2A (0.67) HTR2A
SCHEMBL20766869 0.82 HTR2A (0.50) HTR2A
SCHEMBL30021964 0.80 HTR2A (0.46) HTR2A
SCHEMBL20767223 0.77 HTR2A (0.64) HTR2A
SCHEMBL20766579 0.77 HTR2A (0.64) HTR2A
SCHEMBL20767254 0.76 HTR2A (0.56) HTR2A
SCHEMBL26144324 0.76 HTR2A (0.46) HTR2A
SCHEMBL30523682 0.76 HTR2A (0.63) HTR2A
SCHEMBL23673592 0.76 ACKR3 (0.44) HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019040105-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO claimed
WO-2019040105-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO disclosed